EPO 20000 UNT/ML Injectable Solution [Epogen]

RxCUI
212218
RxNorm name
EPO 20000 UNT/ML Injectable Solution [Epogen]
Display name
EPO 20000 UNT/ML Injectable Solution [Epogen]
Full name
EPO 20000 UNT/ML Injectable Solution [Epogen]
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103234Epogen/Procritepoetin alfa351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EPOGENEPOETIN ALFAAmgen, Inc1f2d0b28-9cc5-4523-80b8-637fdaf3f7a52026-06-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 212218

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5EPO 20000 UNT/ML Injectable Solution [Epogen]SY136These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 198920251105
1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5epoetin alfa 20000 UNT/ML Injectable Solution [Epogen]SBD136These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 198920251105
1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5Epogen 20000 UNT/ML Injectable SolutionSY136These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 198920251105
1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5ERYTHROPOIETIN 20000 UNT/ML Injectable Solution [Epogen]SY136These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 198920251105
1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5EPOGEN 20,000 UNT/ML Injectable SolutionPSN136These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 198920251105
1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5Epogen (epoetin alfa 20,000 UNT/ML) Injectable SolutionSY136These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 198920251105